This profile was programmatically compiled from public sources. Take control to ensure accuracy, share updates, and connect with industry R&D teams.
About
Focuses on molecular imaging and radiotheranostics in oncology, integrating PET/CT, PET-guided radiotherapy planning, and biomarker-driven risk stratification. Work spans radiopharmaceutical development, digital pathology and AI, radiogenomics, and spatial transcriptomics, with emphasis on prostate cancer.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.